54868-5289 Gleevec - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

54868-5289

Brand Name:

Gleevec

Generic Name:

Imatinib Mesylate

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Packages:

Code: 54868-5289-00

Description:

Effective Date: Oct. 7, 2005

Discontinued: June 30, 2013

Code: 54868-5289-01

Description:

Effective Date: Oct. 7, 2005

Discontinued: June 30, 2013

Code: 54868-5289-02

Description:

Effective Date: Oct. 7, 2005

Discontinued: June 30, 2013

Code: 54868-5289-03

Description:

Effective Date: Oct. 7, 2005

Discontinued: June 30, 2013

Code: 54868-5289-04

Description:

Effective Date: Oct. 7, 2005

Discontinued: June 30, 2013

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

No Longer Used